PROGNOSDX HEALTH

prognosdx-health-logo

PrognosDx Health, Inc., a biotechnology company, develops and commercializes epigenetic tests based on histone modification patterns. The company also provides services, such as pharmaceutical research-clinical sample analysis, clinical patient sample analysis tests for other cancers, and prostate cancer patient prognosis test. Its products are used in the development of cancer prognostic assays, therapeutic response prediction assays, and research tools and reagents. The companyโ€™s tissue-based global cellular histone biomarkers are prognostic for various cancers, such as prostate, pancreatic, breast, bladder, kidney, gastrics, colon, and lung cancer. PrognosDx Health, Inc. was incorporated in 2008 and is based in Palo Alto, California.

#SimilarOrganizations #People #Website #More

PROGNOSDX HEALTH

Social Links:

Industry:
Biotechnology Health Care Medical Device

Founded:
2008-01-01

Address:
Palo Alto, California, United States

Country:
United States

Website Url:
http://www.prognosdx.com

Total Employee:
1+

Status:
Closed

Contact:
5105270804

Email Addresses:
[email protected]

Total Funding:
10 K USD

Technology used in webpage:
Wix Wix DNS Web.com Email


Similar Organizations

aragon-surgical-logo

Aragon Surgical

Aragon Surgical develops and commercializes surgical products that reduce operative time and improve patient safety.

control-medical-technology-logo

Control Medical Technology

Control Medical Technology develops and commercializes patient care devices for physicians, nurses, and technicians.

healeon-medical-inc-logo

Healeon Medical, Inc.

Develop and commercialize next generation protocols that improve isolation of regenerative cells.

sierra-surgical-logo

Sierra Surgical

Sieraa Surgical develops minimally-invasive surgical systems based on female sterilization technologies.

sonosite-logo

Sonosite

Sonosite innovates, develops and commercializes ultrasound machines used in the clinical and pre-clinical markets.

not_available_image

Xillix

Xillix has develops and commercializes medical imaging technologies for detection and localization of cancer.

Current Employees Featured

not_available_image

Joseph J. Vallner
Joseph J. Vallner Chief Executive Officer & Board Member @ PrognosDx Health
Chief Executive Officer & Board Member

Founder


babak-n-alizadeh_image

Babak N. Alizadeh

kamran-tahamtanzadeh_image

Kamran Tahamtanzadeh

Official Site Inspections

http://www.prognosdx.com

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.186
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "PrognosDx Health"

PrognosDx Health - Crunchbase Company Profile & Funding

PrognosDx Health, Inc., a biotechnology company, develops and commercializes epigenetic tests based on histone modification patterns. The company also provides services, such as โ€ฆSee details»

PrognosDx Health - PitchBook

PrognosDx Health General Information Description. Operator of a biotechnology company intended to develop drugs for cancer treatment. The company's drugs are developed for โ€ฆSee details»

Company Profile for PrognosDx Health, Inc. | Business Wire

Apr 1, 2011 Company: PrognosDx Health, Inc. Headquarters Address: 530 University Ave. Mail Box # 203 Palo Alto, CA 94301See details»

PrognosDx Health - Products, Competitors, Financials, Employees ...

PrognosDx's tissue-based global cellular histone biomarkers have been confirmed by researchers to be prognostic for multiple cancers and demonstrated by scientific founders in a study โ€ฆSee details»

PrognosDx Health Board of Directors Appoints Joseph J. Vallner, โ€ฆ

Nov 1, 2013 Palo Alto, CA. โ€“ October 24, 2013 โ€“ PrognosDx Health, Inc., a leader in the field of cancer epigenetics, today announced that industry veteran Joseph J. Vallner ...See details»

PrognosDx Health - Contacts, Employees, Board Members

Organization. PrognosDx Health . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. โ€ฆSee details»

PrognosDx Health - Funding, Financials, Valuation & Investors

PrognosDx Health has raised a total of . obfuscated. obfuscated. in funding over 1 round. This was a Debt Financing round raised on May 17, 2011. Unlock for free . ... How much funding โ€ฆSee details»

PrognosDx Health | VentureRadar

PrognosDxโ€™s technology is based on a breakthrough discovery that revealed the role of chemical changes to specific sites on histone proteins as powerful prognostic markers for many cancers โ€ฆSee details»

Real-World Health Data Marketplace | Prognos Health

TRUSTED. Harmonized and enriched data from diverse sources that trust Prognos to implement rigorous data validation and verification processes to ensure accuracy, completeness, and appropriate use.See details»

GeneDx and Prognos Health Announce Strategic Partnership to โ€ฆ

Jul 19, 2023 Partnership allows commercial biopharma companies to leverage real-time data within comprehensive Prognos Marketplace to provide available treatment options for patientsSee details»

PrognosDx, Accium team on histone biomarker tests

Oct 26, 2011 PrognosDx Health is combining its epigenetics technology with Accium BioSciences' accelerator mass spectronomy platform to develop predictive histone biomarker โ€ฆSee details»

PrognosDx Health - Tech Stack, Apps, Patents & Trademarks

PrognosDx Health uses 14 technology products and services including HTML5, GreenSock Animation Platform, and Google Fonts, according to G2 Stack. PrognosDx Health is actively โ€ฆSee details»

GeneDx and Prognos partner to boost treatment for rare diseases

Jul 20, 2023 GeneDx chief transformation officer Kareem Saad stated: โ€œPatients with rare diseases oftentimes have to endure a diagnostic odyssey of approximately eight years, โ€ฆSee details»

GeneDx and Prognos Health Announce Strategic Partnership to โ€ฆ

Jul 19, 2023 --GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, and Prognos Health, the largest real-world integrated data marketplace, today โ€ฆSee details»

PrognosDx Health - Crunchbase

PrognosDx Health develops and commercializes epigenetic tests based on histone modification patterns.See details»

PrognosDx Health Board of Directors Appoints Joseph J ... - BioSpace

Oct 29, 2013 PrognosDxโ€™s Board of Directors Member and Executive Director of the Molecular Medicine Research Institute Edward P. Amento, M.D., said, "We are honored to have Dr. โ€ฆSee details»

GeneDx and Prognos Health Announce Strategic Partnership to โ€ฆ

Jul 19, 2023 Partnership allows commercial biopharma companies to leverage real-time data within comprehensive Prognos Marketplace to provide available treatment options for โ€ฆSee details»

Working At PrognosDx Health: Company Overview and Culture

Learn about working at PrognosDx Health from employee reviews and detailed data on culture, salaries, demographics, management, financial, and more. Find out what it's like to work at โ€ฆSee details»

PrognosDx, MMRI Ink Epigenetics R&D Collaboration

Jul 8, 2013 NEW YORK (GenomeWeb News) โ€“ PrognosDx Health and the Molecular Medicine Research Institute announced recently a broad collaborative R&D agreement aimed at using โ€ฆSee details»

GeneDx and Prognos Health Announce Strategic Partnership to

Jul 19, 2023 NEW YORK and STAMFORD, Conn., July 19, 2023 (GLOBE NEWSWIRE) -- GeneDx, a leader in delivering improved health outcomes through genomic and clinical โ€ฆSee details»

linkstock.net © 2022. All rights reserved